-
2
-
-
0030483045
-
Leptomeningeal carcinomatosis in patients with lung cancer
-
K. Kimura H. Sakai H. Sumimoto S. Hibino I. Goto S. Yoneda 1996 Leptomeningeal carcinomatosis in patients with lung cancer Jpn J Lung Cancer 36 879 883 (Pubitemid 27044122)
-
(1996)
Japanese Journal of Lung Cancer
, vol.36
, Issue.7
, pp. 879-883
-
-
Kimura, K.1
Sakai, H.2
Sumimoto, H.3
Hibino, S.4
Goto, I.5
Yoneda, S.6
Noguchi, Y.7
Izumo, T.8
Sakura, M.9
Takeda, F.10
-
3
-
-
0033117810
-
Leptomeningeal carcinomatosis
-
DOI 10.1053/ctrv.1999.0119
-
S.A. Grossman M.J. Krabak 1999 Leptomeningeal carcinomatosis Cancer Treat Rev 25 103 119 (Pubitemid 29353669)
-
(1999)
Cancer Treatment Reviews
, vol.25
, Issue.2
, pp. 103-119
-
-
Grossman, S.A.1
Krabak, M.J.2
-
5
-
-
0020040396
-
Diagnosis and treatment of leptomeningeal metastases from solid tumors: Experience with 90 patients
-
W.R. Wasserstrom J.P. Glass J.B. Posner 1982 Diagnosis and treatment of leptomeningeal metastases from solid tumors. Experience with 90 patients Cancer 49 759 772 (Pubitemid 12165435)
-
(1982)
Cancer
, vol.49
, Issue.4
, pp. 759-772
-
-
Wasserstrom, W.R.1
Glass, J.P.2
Posner, J.B.3
-
6
-
-
0034758726
-
Tyrosine kinase inhibitors-ZD1839 (Iressa)
-
DOI 10.1097/00001622-200111000-00012
-
C.L. Arteaga D.H. Johnson 2001 Tyrosine kinase inhibitors-ZD1839 (Iressa) Curr Opin Oncol 13 491 498 (Pubitemid 33027902)
-
(2001)
Current Opinion in Oncology
, vol.13
, Issue.6
, pp. 491-498
-
-
Arteaga, C.L.1
Johnson, D.H.2
-
7
-
-
34347236528
-
Gender difference as a prognostic factor in patients undergoing resection of non-small cell lung cancer
-
DOI 10.1007/s00595-006-3453-9
-
T. Hanagiri K. Sugio H. Uramoto T. So Y. Ichiki M. Sugaya 2007 Gender difference as a prognostic factor in patients undergoing resection of non-small cell lung cancer Surg Today 37 546 551 (Pubitemid 46998945)
-
(2007)
Surgery Today
, vol.37
, Issue.7
, pp. 546-551
-
-
Hanagiri, T.1
Sugio, K.2
Uramoto, H.3
So, T.4
Ichiki, Y.5
Sugaya, M.6
Ono, K.7
Yasuda, M.8
Nozoe, T.9
Yasumoto, K.10
-
8
-
-
2642539590
-
Outcomes of patients with advanced non-small cell lung cancer treated with gefitinib (ZD1839, 'Iressa') on an expanded access study
-
DOI 10.1016/j.lungcan.2003.12.014, PII S0169500204000066
-
P.A. Jänne S. Gurubhagavatula B.Y. Yeap J. Lucca P. Ostler A.T. Skarin 2004 Outcomes of patients with advanced non-small cell lung cancer treated with gefitinib (ZD1839, "Iressa") on an expanded access study Lung Cancer 44 221 230 (Pubitemid 38482055)
-
(2004)
Lung Cancer
, vol.44
, Issue.2
, pp. 221-230
-
-
Janne, P.A.1
Gurubhagavatula, S.2
Yeap, B.Y.3
Lucca, J.4
Ostler, P.5
Skarin, A.T.6
Fidias, P.7
Lynch, T.J.8
Johnson, B.E.9
-
9
-
-
0142055937
-
Efficacy of Gefitinib, an Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase, in Symptomatic Patients with Non-Small Cell Lung Cancer: A Randomized Trial
-
DOI 10.1001/jama.290.16.2149
-
M.G. Kris R.B. Natale R.S. Herbst T.J. Lynch Jr D. Prager C.P. Belani 2003 Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer: a randomized trial JAMA 290 2149 2158 (Pubitemid 37432975)
-
(2003)
Journal of the American Medical Association
, vol.290
, Issue.16
, pp. 2149-2158
-
-
Kris, M.G.1
Natale, R.B.2
Herbst, R.S.3
Lynch Jr., T.J.4
Prager, D.5
Belani, C.P.6
Schiller, J.H.7
Kelly, K.8
Spiridonidis, H.9
Sandler, A.10
Albain, K.S.11
Cella, D.12
Wolf, M.K.13
Averbuch, S.D.14
Ochs, J.J.15
Kay, A.C.16
-
10
-
-
1842509828
-
Bronchioloalveolar pathologic subtype and smoking history predict sensitivity to gefitinib in advanced non-small-cell lung cancer
-
DOI 10.1200/JCO.2004.08.158
-
V.A. Miller M.G. Kris N. Shah J. Patel C. Azzoli J. Gomez 2004 Bronchioloalveolar pathologic subtype and smoking history predict sensitivity to gefitinib in advanced non-small-cell lung cancer J Clin Oncol 22 1103 1109 (Pubitemid 41095044)
-
(2004)
Journal of Clinical Oncology
, vol.22
, Issue.6
, pp. 1103-1109
-
-
Miller, V.A.1
Kris, M.G.2
Shah, N.3
Patel, J.4
Azzoli, C.5
Gomez, J.6
Krug, L.M.7
Pao, W.8
Rizvi, N.9
Pizzo, B.10
Tyson, L.11
Venkatraman, E.12
Ben-Porat, L.13
Memoli, N.14
Zakowski, M.15
Rusch, V.16
Heelan, R.T.17
-
11
-
-
6044264104
-
EGFR mutations in lung cancer: Correlation with clinical response to gefitinib therapy
-
J.G. Paez P.A. Jänne J.C. Lee S. Tracy H. Greulich S. Gabriel 2004 EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy Science 81 61 69
-
(2004)
Science
, vol.81
, pp. 61-69
-
-
Paez, J.G.1
Jänne, P.A.2
Lee, J.C.3
Tracy, S.4
Greulich, H.5
Gabriel, S.6
-
12
-
-
26444531911
-
Gefitinib is also active for carcinomatous meningitis in NSCLC
-
DOI 10.1016/j.lungcan.2005.05.022, PII S0169500205002795
-
M.K. Kim K.H. Lee J.K. Lee J.H. Choi M.S. Hyun 2005 Gefitinib is also active for carcinomatous meningitis in NSCLC Lung Cancer 50 265 269 (Pubitemid 41427903)
-
(2005)
Lung Cancer
, vol.50
, Issue.2
, pp. 265-269
-
-
Min, K.K.1
Kyung, H.L.2
Jae, K.L.3
Joon, H.C.4
Hyun, M.S.5
-
13
-
-
33746911613
-
Successful re-treatment with gefitinib for carcinomatous meningitis as disease recurrence of non-small-cell lung cancer
-
DOI 10.1016/j.lungcan.2006.05.016, PII S0169500206002364
-
N. Hashimoto K. Imaizumi T. Honda T. Kawabe T. Nagasaka K. Shimokata 2006 Successful re-treatment with gefitinib for carcinomatous meningitis as disease recurrence of non-small-cell lung cancer Lung Cancer 53 387 390 (Pubitemid 44189562)
-
(2006)
Lung Cancer
, vol.53
, Issue.3
, pp. 387-390
-
-
Hashimoto, N.1
Imaizumi, K.2
Honda, T.3
Kawabe, T.4
Nagasaka, T.5
Shimokata, K.6
Hasegawa, Y.7
-
14
-
-
33746133544
-
Carcinomatous meningitis from non-small-cell lung cancer responding to gefitinib
-
DOI 10.1007/s10147-005-0558-x
-
M. Sakai S. Ishikawa H. Ito Y. Ozawa T. Yamamoto M. Onizuka 2006 Carcinomatous meningitis from non-small-cell lung cancer responding to gefitinib Int J Clin Oncol 11 243 245 (Pubitemid 44087124)
-
(2006)
International Journal of Clinical Oncology
, vol.11
, Issue.3
, pp. 243-245
-
-
Sakai, M.1
Ishikawa, S.2
Ito, H.3
Ozawa, Y.4
Yamamoto, T.5
Onizuka, M.6
Sakakibara, Y.7
-
15
-
-
0030926263
-
Regional lymph node classification for lung cancer staging
-
C.F. Mountain C.M. Dresler 1997 Regional lymph node classification for lung cancer staging Chest 111 1718 1723 (Pubitemid 27260108)
-
(1997)
Chest
, vol.111
, Issue.6
, pp. 1718-1723
-
-
Mountain, C.F.1
Dresler, C.M.2
-
16
-
-
0037676125
-
Survival and neurologic outcomes in a randomized trial of motexafin gadolinium and whole-brain radiation therapy in brain metastases
-
DOI 10.1200/JCO.2003.12.122
-
M.P. Mehta P. Rodrigus C.H. Terhaard A. Rao J. Suh W. Roa 2003 Survival and neurologic outcomes in a randomized trial of motexafin gadolinium and whole-brain radiation therapy in brain metastases J Clin Oncol 21 2529 2536 (Pubitemid 46606335)
-
(2003)
Journal of Clinical Oncology
, vol.21
, Issue.13
, pp. 2529-2536
-
-
Mehta, M.P.1
Rodrigus, P.2
Terhaard, C.H.J.3
Rao, A.4
Suh, J.5
Roa, W.6
Souhami, L.7
Bezjak, A.8
Leibenhaut, M.9
Komaki, R.10
Schultz, C.11
Timmerman, R.12
Curran, W.13
Smith, J.14
Phan, S.-C.15
Miller, R.A.16
Renschler, M.F.17
-
17
-
-
0347319031
-
Quality-of-life benefits and evidence of antitumor activity for patients with brain metastases treated with gefitinib
-
A. Katz P. Zalewski 2003 Quality-of-life benefits and evidence of antitumor activity for patients with brain metastases treated with gefitinib Br J Cancer 89 15 18
-
(2003)
Br J Cancer
, vol.89
, pp. 15-18
-
-
Katz, A.1
Zalewski, P.2
-
19
-
-
67651189806
-
Mechanisms of enhanced radiation response following epidermal growth factor receptor signaling inhibition by erlotinib (Tarceva)
-
P. Chinnaiyan S. Huang G. Vallabhaneni E. Armstrong S. Varambally S.A. Tomlins 2005 Mechanisms of enhanced radiation response following epidermal growth factor receptor signaling inhibition by erlotinib (Tarceva) Cancer Res 47 129 138
-
(2005)
Cancer Res
, vol.47
, pp. 129-138
-
-
Chinnaiyan, P.1
Huang, S.2
Vallabhaneni, G.3
Armstrong, E.4
Varambally, S.5
Tomlins, S.A.6
-
20
-
-
18144400958
-
Ventriculoperitoneal shunt in patients with leptomeningeal metastasis
-
DOI 10.1212/01.WNL.0000160396.69050.DC
-
A.M. Omuro E.C. Lallana M.H. Bilsky L.M. DeAngelis 2005 Ventriculoperitoneal shunt in patients with leptomeningeal metastasis Neurology 64 1625 1627 (Pubitemid 40617704)
-
(2005)
Neurology
, vol.64
, Issue.9
, pp. 1625-1627
-
-
Omuro, A.M.P.1
Lallana, E.C.2
Bilsky, M.H.3
DeAngelis, L.M.4
-
21
-
-
0017201622
-
The peritoneal complications of ventriculo-peritoneal shunts
-
P. King 1976 The peritoneal complications of ventriculo-peritoneal shunts Aust N Z J Surg 46 372 377
-
(1976)
Aust N Z J Surg
, vol.46
, pp. 372-377
-
-
King, P.1
-
22
-
-
0019489463
-
Metastasis of intracranial germinoma through a ventriculoperitoneal shunt
-
DOI 10.1002/1097-0142(19810815)48:4<1033::AID-CNCR2820480430>3.0. CO;2-R
-
I.C. Haimovic L. Sharer R.A. Hyman H.R. Beresford 1981 Metastasis of intracranial germinoma through a ventriculoperitoneal shunt Cancer 48 1033 1036 (Pubitemid 11049109)
-
(1981)
Cancer
, vol.48
, Issue.4
, pp. 1033-1036
-
-
Haimovic, I.C.1
Sharer, L.2
Hyman, R.A.3
Beresford, H.R.4
|